ARTICLE | Company News
Arrowhead, M.D. Anderson Cancer Center deal
January 3, 2011 8:00 AM UTC
The center granted Arrowhead an exclusive, worldwide license to technology related targeting the prohibitin 1 (PHB1) to treat weight-loss and obesity-related metabolic conditions. Arrowhead launched ...